Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/1999
02/02/1999US5866353 Electro chemical biosensor containing diazacyanine mediator for co-enzyme regeneration
02/02/1999US5866352 Kit for fructosamine determination
02/02/1999US5866351 CD4+ T-lymphocyte proteases and genes encoding said proteases
02/02/1999US5866350 Method for the immunological determination of a biological material in a sample
02/02/1999US5866349 Method for determination of glucose in whole blood and cuvette and photometer for carrying out said method
02/02/1999US5866348 Bioluminescence measurement system
02/02/1999US5866345 Typically single-use, modules capable of receiving and rapidly conducting a predetermined assay protocol on a fluid sample.
02/02/1999US5866338 Cell cycle checkpoint genes
02/02/1999US5866337 Method to detect mutations in a nucleic acid using a hybridization-ligation procedure
02/02/1999US5866336 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
02/02/1999US5866334 Determination and identification of active compounds in a compound library
02/02/1999US5866333 Screening methods to detect mRNA targets of editing enzymes
02/02/1999US5866331 Single molecule detection by in situ hybridization
02/02/1999US5866330 Isolating and analyzing short defined sequence tags corresponding to expressed genes
02/02/1999US5866329 Method and probe for detection of gene associated with liver neoplastic disease
02/02/1999US5866328 Fast DNA sequence determination method by measuring energy of base pairing or unpairing of nucleic acid sequences and use thereof in sequencing and diagnostics
02/02/1999US5866327 Association of kinensin with sensitivity to chemotherapeutic drugs
02/02/1999US5866326 Hybrids
02/02/1999US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
02/02/1999US5866321 Accuracy
02/02/1999US5866320 Detection antibodies
02/02/1999US5866319 Dna probe capacble of hybridizing with genome
02/02/1999US5866318 Administering to nerve cells apopototic stimulant; calibration
02/02/1999US5866140 Type I surface antigen associated with staphylococcus epidermidis
02/02/1999US5866119 Hybridization; complexing
02/02/1999US5866098 Paracrine signal assay
02/02/1999CA2082906C Electrophoretic resolution of single strand dna by asymmetric field inversion
02/02/1999CA2019872C Method and kit for determining the functional activity of protein s in human plasma
02/02/1999CA1340373C Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
02/02/1999CA1340365C Method for ascertaining the history of a condition of the body from a single blood sample
02/01/1999CA2244403A1 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array
02/01/1999CA2238672A1 Seca
02/01/1999CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis
01/1999
01/29/1999CA2239266A1 Novel histidine kinase
01/28/1999WO1999004440A1 Microelectronic components and electronic networks comprising dna
01/28/1999WO1999004266A2 Interactions of atm, atr or dna-pk with p53
01/28/1999WO1999004265A2 Cancer associated nucleic acids and polypeptides
01/28/1999WO1999004264A1 Method for identifying modifiers of the leptin: leptin receptor interaction
01/28/1999WO1999004238A2 Reagents and methods for diagnosis and prognosis of proliferative disorders
01/28/1999WO1999004237A2 Diagnosis of spongiform encephalopathies using prionins
01/28/1999WO1999004043A1 Telemedicine
01/28/1999WO1999004042A1 Synthetic oligonucleotide-peptide conjugates and methods of use
01/28/1999WO1999004041A1 Methods and compositions for modulating melting temperatures of nucleic acids
01/28/1999WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
01/28/1999WO1999004039A1 Methods and materials for detecting e. coli o157 in polymerase chain reaction assays
01/28/1999WO1999004038A2 Biallelic markers for use in constructing a high density disequilibrium map of the human genome
01/28/1999WO1999004037A1 Detection of k-ras mutations in cancer
01/28/1999WO1999004036A1 Cd44 based cancer detection
01/28/1999WO1999004035A1 In vitro method for providing templates for dna sequencing
01/28/1999WO1999004034A1 Primers for obtaining highly informative dna markers
01/28/1999WO1999004033A1 Assay to detect inhibitors of i-kappa-b proteolyse
01/28/1999WO1999004032A1 Culture medium for detecting pathogenic bacteria of the genus listeria and method for identifying said bacteria
01/28/1999WO1999004013A2 The induction of stress-related factors in plants
01/28/1999WO1999004011A2 Hiv-1 group o antigens and uses thereof
01/28/1999WO1999004010A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
01/28/1999WO1999004000A1 Adipocyte-specific protein homologs
01/28/1999WO1999003997A1 Humanized and green fluorescent protein genes and methods
01/28/1999WO1999003995A1 T-cell receptor beta-like protein
01/28/1999WO1999003991A1 Proteins mediating switch recombination
01/28/1999WO1999003990A1 64 human secreted proteins
01/28/1999WO1999003989A1 Human atp-binding cassette transport protein
01/28/1999WO1999003872A1 Nucleic acid ladders
01/28/1999WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
01/28/1999WO1999003494A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase
01/28/1999WO1998049341A3 Polynucleotide sequencing using semi-degenerate primers
01/28/1999WO1998048047A3 Characterising dna
01/28/1999WO1998048045A3 Method for non-invasive identification of malignant lung tumors
01/28/1999WO1998048041A3 Dna probes, method and kit for identifying antibiotic-resistant strains of bacteria
01/28/1999WO1998046788A3 Primers and methods for the detection of disseminated tumor cells
01/28/1999WO1998046729A3 Enzyme assay for mutant firefly luciferase
01/28/1999WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
01/28/1999WO1998045477A3 Methods for assessing cardiovascular status and compositions for use thereof
01/28/1999WO1998038510A3 Laboratory in a disk
01/28/1999WO1998038324A3 Chimeric cell-surface receptors that undergo antigen-induced association
01/28/1999DE19732086A1 Quantification of eubacteria in competitive polymerase chain reaction
01/28/1999DE19731990A1 Verfahren zur Herstellung und Identifizierung von neuen Hydrolasen mit verbesserten Eigenschaften Process for the preparation and identification of new hydrolases with improved properties
01/28/1999DE19731670A1 Purification of nucleic acid by treatment with anion-exchange resin
01/28/1999DE19731465A1 Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren The use of control areas for the detection of interfering samples in a detection method
01/28/1999DE19731292A1 Nucleinsäuremolekül, Kit und Verwendung Nucleic acid molecule kit and use
01/28/1999CA2296815A1 64 human secreted proteins
01/28/1999CA2296666A1 T-cell receptor beta-like protein
01/28/1999CA2296530A1 Adipocyte-specific protein homologs
01/28/1999CA2296508A1 Structure of the ankyrin binding domain of a alpha-na,k-atpase
01/28/1999CA2296447A1 Human atp-binding cassette transport protein
01/28/1999CA2296442A1 Hiv-1 group o antigens and uses thereof
01/28/1999CA2296416A1 Assays therapeutic methods and means
01/28/1999CA2296401A1 Biallelic markers for use in constructing a high density disequilibrium map of the human genome
01/28/1999CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
01/28/1999CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
01/28/1999CA2294294A1 Telemedicine
01/28/1999CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33
01/27/1999EP0893691A1 Methods for diagnosis and therapy of autoimmunedisease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
01/27/1999EP0893503A2 Regulator protein from Staphylococcus aureus
01/27/1999EP0893502A2 GreA from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0892857A1 Analysis of dna
01/27/1999EP0892856A1 A method for the amplification and detection of a nucleic acid fragment of interest